StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for iBio

iBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More iBio figures

See a number that looks wrong?